<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03636321</url>
  </required_header>
  <id_info>
    <org_study_id>AS.fac.med.55</org_study_id>
    <nct_id>NCT03636321</nct_id>
  </id_info>
  <brief_title>Stented Biliary Anastomosis in Living Donor Liver Transplantation</brief_title>
  <official_title>Randomized Controlled Clinical Trial Of Stented Versus Stentless Biliary Anastomosis In Living Donor Liver Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alaa Mstafa Hassan Sewefy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Minia University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Determination of biliary complications in stented group compared to duct to duct anastomosis
      without stent
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      30 patients included in the study. patients will be randomly allocated in two equal groups.
      In group A anastomosis will be done on intraductal stent and in group B anastomosis done
      without stent .the patients will be followed for one year to compare the result of two groups
      as regard biliary complications.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 10, 2018</start_date>
  <completion_date type="Actual">November 10, 2019</completion_date>
  <primary_completion_date type="Actual">November 10, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>biliary complications after living donor liver transplantation</measure>
    <time_frame>one year</time_frame>
    <description>incidence of biliary complications after living donor liver transplantation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>biliary complications</measure>
    <time_frame>one year</time_frame>
    <description>types of biliary complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>biliary related mortality</measure>
    <time_frame>one year</time_frame>
    <description>mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>rate of cholangitis</measure>
    <time_frame>3 months</time_frame>
    <description>rate of cholangitis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hospital stay</measure>
    <time_frame>one month</time_frame>
    <description>hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time 2 biliary complications</measure>
    <time_frame>one year</time_frame>
    <description>time 2 biliary complications</description>
  </secondary_outcome>
  <other_outcome>
    <measure>skeletonization of duct</measure>
    <time_frame>10 hours</time_frame>
    <description>skeletonization of duct</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Liver Transplant</condition>
  <arm_group>
    <arm_group_label>intraductal stent</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>in this group ,patients candidate for living donor liver transplantation duct to duct biliary anastomosis with internal biliary stent</description>
  </arm_group>
  <arm_group>
    <arm_group_label>stentless</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>in this group ,patients candidate for living donor liver transplantation duct to duct biliary anastomosis will done without internal biliary</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>living donor liver transplantation with internal biliary stent</intervention_name>
    <description>living donor liver transplantation without internal biliary stent</description>
    <arm_group_label>intraductal stent</arm_group_label>
    <arm_group_label>stentless</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult patients eligible for a liver transplantation

          -  patients' written informed consent signed.

        Exclusion Criteria:

          -  biliary reconstruction requires a hepatico-jejunostomy for anatomical/biliary disease
             reason.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Air force spcialized hospital</name>
      <address>
        <city>Cairo</city>
        <zip>11865</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>August 2, 2018</study_first_submitted>
  <study_first_submitted_qc>August 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 17, 2018</study_first_posted>
  <last_update_submitted>May 14, 2020</last_update_submitted>
  <last_update_submitted_qc>May 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Minia University</investigator_affiliation>
    <investigator_full_name>Alaa Mstafa Hassan Sewefy</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <keyword>living donor liver transplantation</keyword>
  <keyword>intraductal stent</keyword>
  <keyword>biliary complications after liver transplantation</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

